These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8387366)
21. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system. De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210 [TBL] [Abstract][Full Text] [Related]
22. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors. Convents A; De Backer JP; Convents D; Vauquelin G Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739 [TBL] [Abstract][Full Text] [Related]
23. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631 [TBL] [Abstract][Full Text] [Related]
24. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. Remaury A; Paris H J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166 [TBL] [Abstract][Full Text] [Related]
25. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide. Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497 [TBL] [Abstract][Full Text] [Related]
27. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Mallard NJ; Hudson AL; Nutt DJ Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565 [TBL] [Abstract][Full Text] [Related]
28. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase. Renouard A; Widdowson PS; Cordi A Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932 [TBL] [Abstract][Full Text] [Related]
29. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors? Zonnenchein R; Diamant S; Atlas D Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751 [TBL] [Abstract][Full Text] [Related]
30. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites. Sastre M; García-Sevilla JA J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564 [TBL] [Abstract][Full Text] [Related]
31. The modulation of [3H]noradrenaline and [3H]serotonin release from rat brain synaptosomes is not mediated by the alpha 2B-adrenoceptor subtype. Gobbi M; Frittoli E; Mennini T Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):382-6. PubMed ID: 1979424 [TBL] [Abstract][Full Text] [Related]
32. Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype. Sastre M; García-Sevilla JA J Neurochem; 1994 Sep; 63(3):1077-85. PubMed ID: 7914222 [TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex. Bricca G; Greney H; Dontenwill-Kieffer M; Zhang J; Belcourt A; Bousquet P Neurochem Int; 1993 Feb; 22(2):153-63. PubMed ID: 8439769 [TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution. Legrand C; Mhaouty S; Rigolot C; Maltier JP J Pharmacol Exp Ther; 1993 Jul; 266(1):439-49. PubMed ID: 8101224 [TBL] [Abstract][Full Text] [Related]
35. Characterization of subtypes of alpha-2 adrenoceptors in the human brain. Ordway GA; Jaconetta SM; Halaris AE J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286 [TBL] [Abstract][Full Text] [Related]
36. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex. Howe JR; Yaksh TL Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820 [TBL] [Abstract][Full Text] [Related]
37. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites. Langin D; Paris H; Lafontan M Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes. Wallace DR; Muskardin DT; Zahniser NR Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601 [TBL] [Abstract][Full Text] [Related]
39. [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site. MacKinnon AC; Brown CM; Spedding M; Kilpatrick AT Br J Pharmacol; 1989 Dec; 98(4):1143-50. PubMed ID: 2558757 [TBL] [Abstract][Full Text] [Related]
40. [3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors. Langin D; Lafontan M; Stillings MR; Paris H Eur J Pharmacol; 1989 Aug; 167(1):95-104. PubMed ID: 2570706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]